Found: 9
Select item for more details and to access through your institution.
MicroRNA-122 in human cancers: from mechanistic to clinical perspectives.
- Published in:
- Cancer Cell International, 2023, v. 23, n. 1, p. 1, doi. 10.1186/s12935-023-02868-z
- By:
- Publication type:
- Article
microRNA-184 in the landscape of human malignancies: a review to roles and clinical significance.
- Published in:
- Cell Death Discovery, 2023, v. 9, n. 1, p. 1, doi. 10.1038/s41420-023-01718-1
- By:
- Publication type:
- Article
Circulating microRNA-122, microRNA-126-3p and microRNA-146a are associated with inflammation in patients with pre-diabetes and type 2 diabetes mellitus: A case control study.
- Published in:
- PLoS ONE, 2021, v. 16, n. 6, p. 1, doi. 10.1371/journal.pone.0251697
- By:
- Publication type:
- Article
Non-coding RNAs/DNMT3B axis in human cancers: from pathogenesis to clinical significance.
- Published in:
- Journal of Translational Medicine, 2023, v. 21, n. 1, p. 1, doi. 10.1186/s12967-023-04510-y
- By:
- Publication type:
- Article
Non-coding RNAs/DNMT3B axis in human cancers: from pathogenesis to clinical significance.
- Published in:
- Journal of Translational Medicine, 2023, v. 21, n. 1, p. 1, doi. 10.1186/s12967-023-04510-y
- By:
- Publication type:
- Article
The Relationship between Mutation in HOXB1 Gene and Acute Myeloid Leukemia.
- Published in:
- Iranian Journal of Pediatric Hematology & Oncology, 2019, v. 9, n. 4, p. 229
- By:
- Publication type:
- Article
Effects of synbiotic supplementation on gut microbiome, serum level of TNF-α, and expression of microRNA-126 and microRNA-146a in patients with type 2 diabetes mellitus: study protocol for a double-blind controlled randomized clinical trial.
- Published in:
- 2020
- By:
- Publication type:
- journal article
Microbiome modulation in inflammatory diseases: Progress to microbiome genetic engineering.
- Published in:
- Cancer Cell International, 2023, v. 23, n. 1, p. 1, doi. 10.1186/s12935-023-03095-2
- By:
- Publication type:
- Article
Developing nanosize carrier systems for Amphotericin‐B: A review on the biomedical application of nanoparticles for the treatment of leishmaniasis and fungal infections.
- Published in:
- Biotechnology Journal, 2024, v. 19, n. 1, p. 1, doi. 10.1002/biot.202300462
- By:
- Publication type:
- Article